Literature DB >> 14638753

Genomic location and variation of the gene for CRS, a complement binding protein in the M57 strains of Streptococcus pyogenes.

Michael Binks1, David McMillan, Kadaba S Sriprakash.   

Abstract

All isolates of serotype M1 of group A streptococci possess a gene for streptococcal inhibitor of complement (SIC) in the mga regulon, which harbors genes for other virulence factors, such as M and M-like proteins, C5a peptidase, and a regulator. In serotype M57 the gene for a protein that is closely related to SIC (crs57) is located outside the mga regulon. We mapped the location of the crs57 gene in six strains of emm57 (gene encoding the M57 protein) sequence types to an intergenic region between the ABC transporter gene (SPy0778) and the gene for a small ribosomal protein (rpsU). The noncoding sequences on both sides of crs57 exhibited high degrees of identity to the corresponding regions of sic from M1 strains. This included one of the inverted repeat sequences of IS1562 but not the insertion element itself. These observations suggest that crs57 was recently acquired by serotype M57 or its progenitor via horizontal acquisition from serotype M1. The six emm57 sequence type isolates analyzed in this study belong to two distinct molecular types (vir types VT8 and VT101). Although the crs57 sequences from VT8 strains had very few substitution mutations, the VT101 crs57 sequence had a large number of such mutations. The CRS57 proteins from these strains are secretory products and have the ability to bind to complement proteins. All these proteins contain several tryptophan-rich repeats designated DWS motifs and internal repeat sequences. In all of these structural and biochemical characteristics CRS57 resembles SIC from M1 strains. Hence, CRS57 has a functional role similar to that of SIC in an M1 strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638753      PMCID: PMC308880          DOI: 10.1128/IAI.71.12.6701-6706.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

Authors:  B A Fernie-King; D J Seilly; C Willers; R Würzner; A Davies; P J Lachmann
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Streptolysin O: the C-terminal, tryptophan-rich domain carries functional sites for both membrane binding and self-interaction but not for stable oligomerization.

Authors:  S Weis; M Palmer
Journal:  Biochim Biophys Acta       Date:  2001-02-09

3.  Antibodies to streptococcal inhibitor of complement function and M peptides in a post-streptococcal glomerulonephritis endemic region of Australia.

Authors:  K S Sriprakash; Jon Hartas; Andrew White
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

4.  Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks.

Authors:  James C Smoot; Kent D Barbian; Jamie J Van Gompel; Laura M Smoot; Michael S Chaussee; Gail L Sylva; Daniel E Sturdevant; Stacy M Ricklefs; Stephen F Porcella; Larye D Parkins; Stephen B Beres; David S Campbell; Todd M Smith; Qing Zhang; Vivek Kapur; Judy A Daly; L George Veasy; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

5.  Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells.

Authors:  Nancy P Hoe; Robin M Ireland; Frank R DeLeo; Brian B Gowen; David W Dorward; Jovanka M Voyich; Mengyao Liu; Eugene H Burns; Derek M Culnan; Anthony Bretscher; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  Immunological response mounted by Aboriginal Australians living in the Northern Territory of Australia against Streptococcus pyogenes serum opacity factor.

Authors:  Christine M Gillen; Rebecca J Towers; David J McMillan; Armando Delvecchio; K S Sriprakash; Bart Currie; Berndt Kreikemeyer; Gurusharan S Chhatwal; Mark J Walker
Journal:  Microbiology       Date:  2002-01       Impact factor: 2.777

Review 8.  Multiple ligand binding sites on domain seven of human complement factor H.

Authors:  E Giannakis; D A Male; R J Ormsby; C Mold; T S Jokiranta; S Ranganathan; D L Gordon
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

9.  Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes.

Authors:  K Berggård; E Johnsson; E Morfeldt; J Persson; M Stålhammar-Carlemalm; G Lindahl
Journal:  Mol Microbiol       Date:  2001-10       Impact factor: 3.501

10.  Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence.

Authors:  Stephen B Beres; Gail L Sylva; Kent D Barbian; Benfang Lei; Jessica S Hoff; Nicole D Mammarella; Meng-Yao Liu; James C Smoot; Stephen F Porcella; Larye D Parkins; David S Campbell; Todd M Smith; John K McCormick; Donald Y M Leung; Patrick M Schlievert; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

View more
  8 in total

1.  Seroreactivity against streptococcal DRS (distantly related to SIC) protein is a predictor for end-stage renal failure.

Authors:  Virginia A F Boon; James L Munro; George W Kan; James Burnell; Richard Speare
Journal:  Clin Vaccine Immunol       Date:  2008-08-06

2.  Characterization of a complement-binding protein, DRS, from strains of Streptococcus pyogenes containing the emm12 and emm55 genes.

Authors:  Michael Binks; K S Sriprakash
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 3.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

4.  Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Celia L McNeilly; David J McMillan
Journal:  Front Microbiol       Date:  2014-12-15       Impact factor: 5.640

5.  Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma.

Authors:  Mohan G Karmarkar; Gouri P Hule; Ainslie Cameron; Preeti R Mehta; Uday Khopkar; Niwrutti K Hase; Kadaba S Sriprakash
Journal:  BMC Infect Dis       Date:  2015-03-03       Impact factor: 3.090

6.  Seroprevalence of Streptococcal Inhibitor of Complement (SIC) suggests association of streptococcal infection with chronic kidney disease.

Authors:  Mohan Ganesh Karmarkar; Gouri Pandharinath Hule; Niwrutti Khandu Hase; Preeti Rajeev Mehta; Scott Robert Walter; Kadaba Srinivasa Sriprakash
Journal:  BMC Nephrol       Date:  2013-05-06       Impact factor: 2.388

7.  Comparative analysis of emm type pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor.

Authors:  Vivek Sagar; Rajesh Kumar; Nirmal K Ganguly; Anuradha Chakraborti
Journal:  BMC Microbiol       Date:  2008-09-16       Impact factor: 3.605

8.  Spontaneous mutations in Streptococcus pyogenes isolates from streptococcal toxic shock syndrome patients play roles in virulence.

Authors:  Tadayoshi Ikebe; Takayuki Matsumura; Hisako Nihonmatsu; Hitomi Ohya; Rumi Okuno; Chieko Mitsui; Ryuji Kawahara; Mitsuhiro Kameyama; Mari Sasaki; Naomi Shimada; Manabu Ato; Makoto Ohnishi
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.